Trials / Unknown
UnknownNCT04065750
Exposure to Antibiotics and Incidence of Bacteraemia Caused by Resistant Bacteria
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 45,000 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to identify the risk factors of community-acquired bacteremia to resistant bacteria. As the secondary objectives, the study aims * to describe the episodes of epidemiology of bacteremia (community-acquired and nosocomial) with inpatient patients in APHP. * to research a potential correlation between the incidence of community-acquired bacteremia of studied germs and the evolution of antibiotics consumption in general population in Île de France region. * to distinguish three categories of community-acquired bacteremia: real community-acquired infections, infections beginning in community (patients discharged a community care center within 3 months), the nosocomial infections (patients discharged a health center within 7 jours). Describe the epidemiology of resistance and the differential impact of individual exposure to antibiotics in these three categories. * to identify, according to pathogens, a temporal threshold from which a prior stay in a health center or HAD would impact on the occurrence of a community-acquired bacteremia with a resistant bacterium. * to describe prospectively for follow-up of 1 year for hospitalized patients for a community-acquired or nosocomial bacteremia: mortality at one month and 3 months, re-hospitalization for an infectious episode and isolated bacteria during this later episode.
Detailed description
The investigators will study in particularly individual exposure to antibiotics: exposure in 3 months ou in 12 months, cumulative exposure, hospital- and community-acquired exposure, etc.
Conditions
Timeline
- Start date
- 2023-11-13
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2019-08-22
- Last updated
- 2023-09-21
Source: ClinicalTrials.gov record NCT04065750. Inclusion in this directory is not an endorsement.